BVTV: Moderna’s patent fight
Moderna’s claim that Pfizer’s vaccine uses its intellectual property will not result in the product being pulled from the market. Robert Cyran explains why, even if any settlement is relatively modest, the firms are still fighting.
#COVID #Vaccine #Business #News #Reuters
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
source
In this article:bloomberg, Breaking news, Business, BVTV, Coronavirus, coronavirus vaccine, Covid, covid vaccine, COVID-19, COVID-19 vaccine, Fight, finance, headlines, intellectual property, intellectual property violation, markets today, Moderna, Modernas, mRNA, mRNA technology, mRNA vaccine, news, news today, patent, Pfizer, Pharma, Pharmaceuticals, reuters, reuters youtube, thomson reuters, top news, Vaccine, vaccine patent
